发明名称 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FAMPRIDINE
摘要 This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject fampridine as an add-on therapy to or in combination with laquinimod. This invention also provides a package comprising laquinimod and fampridine for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides fampridine for use as an add-on therapy or in combination with laquinimod in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides a pharmaceutical composition comprising laquinimod and fampridine for use in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and fampridine in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome.
申请公布号 CA2873229(A1) 申请公布日期 2014.01.16
申请号 CA20132873229 申请日期 2013.07.11
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 KAYE, JOEL;TARCIC, NORA
分类号 A61K31/4704;A01N43/42;A01N45/00;A61K31/4409;A61P21/00;A61P25/28 主分类号 A61K31/4704
代理机构 代理人
主权项
地址